Quantitative Assessment of Elagolix Enzyme-Transporter Interplay and Drug–Drug Interactions Using Physiologically Based Pharmacokinetic Modeling

被引：0
|
作者：
Manoj S. Chiney
Juki Ng
John P. Gibbs
Mohamad Shebley
机构：
[1] AbbVie,Clinical Pharmacology and Pharmacometrics
来源：
Clinical Pharmacokinetics | 2020年 / 59卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：617 / 627
页数：10
相关论文
共 50 条
  • [31] Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for atorvastatin and its metabolites
    Zhang, Tao
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 77 : 216 - 229
  • [32] APPLICATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING IN PREDICTING DRUG-DRUG INTERACTIONS FOR TELMISARTAN IN HUMANS
    Kim, Jeong Ho
    Heo, Hyunjin
    Min, Jee Sun
    Kim, Doyun
    Bae, Soo Hyeon
    Bae, Soo Kyung
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S109 - S110
  • [33] Physiologically Based Pharmacokinetic Modeling as a Tool to Predict Drug Interactions for Antibody-Drug Conjugates
    Chen, Yuan
    Samineni, Divya
    Mukadam, Sophie
    Wong, Harvey
    Shen, Ben-Quan
    Lu, Dan
    Girish, Sandhya
    Hop, Cornelis
    Jin, Jin Yan
    Li, Chunze
    CLINICAL PHARMACOKINETICS, 2015, 54 (01) : 81 - 93
  • [34] Quantitative Prediction of Drug-Drug Interactions Involving Inhibitory Metabolites in Drug Development: How Can Physiologically Based Pharmacokinetic Modeling Help?
    Templeton, I. E.
    Chen, Y.
    Mao, J.
    Lin, J.
    Yu, H.
    Peters, S.
    Shebley, M.
    Varma, M. V.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2016, 5 (10): : 505 - 515
  • [35] Application of physiologically based pharmacokinetic modeling to the prediction of drug-drug and drug-disease interactions for rivaroxaban
    Ruijuan Xu
    Weihong Ge
    Qing Jiang
    European Journal of Clinical Pharmacology, 2018, 74 : 755 - 765
  • [36] Application of Physiologically Based Pharmacokinetic Modeling to Evaluate the Drug-Drug and Drug-Disease Interactions of Apatinib
    Liu, Hongrui
    Yu, Yiqun
    Guo, Nan
    Wang, Xiaojuan
    Han, Bing
    Xiang, Xiaoqiang
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [37] Application of physiologically based pharmacokinetic modeling to the prediction of drug-drug and drug-disease interactions for rivaroxaban
    Xu, Ruijuan
    Ge, Weihong
    Jiang, Qing
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (06) : 755 - 765
  • [38] Prediction of drug-drug interaction potential using physiologically based pharmacokinetic modeling
    Min, Jee Sun
    Bae, Soo Kyung
    ARCHIVES OF PHARMACAL RESEARCH, 2017, 40 (12) : 1356 - 1379
  • [39] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING FOR ASSESSMENT OF THE DRUG-DRUG INTERACTION POTENTIAL OF ZAVEGEPANT
    Ke, A.
    Callegari, E.
    Bhardwaj, R.
    Varma, M.
    Muto, C.
    Bertz, R.
    Sahasrabudhe, V.
    Liu, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S107 - S107
  • [40] Physiologically based pharmacokinetic modelling of oxycodone drug-drug interactions
    Rytkonen, Jaana
    Ranta, Veli-Pekka
    Kokki, Merja
    Kokki, Hannu
    Hautajarvi, Heidi
    Rinne, Valtteri
    Heikkinen, Aki T.
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2020, 41 (1-2) : 72 - 88
12345